Emerging perspectives on lipid management: international approaches and global challenges. Editorial Article uri icon

Overview

abstract

  • The rapid growth in the understanding of the relation between cholesterol and coronary heart disease has introduced new challenges to the contemporary management of lipid disorders. The publication of the trials of the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitors (statins) has invigorated support for the lipid hypothesis, and many advances have been made in understanding the mechanisms underlying atherosclerosis and the potential benefits of the statins. Several international groups have issued guidelines about desirable and undesirable lipid values to help clinical decision making. Despite the availability of such principles, there are many challenges to optimal management of lipid disorders.

publication date

  • October 15, 2001

Research

keywords

  • Coronary Artery Disease
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipoproteins

Identity

Scopus Document Identifier

  • 0035887168

Digital Object Identifier (DOI)

  • 10.1016/s0002-9149(01)01895-1

PubMed ID

  • 11676951

Additional Document Info

volume

  • 88

issue

  • 8